Proteomic identification of altered proteins in skeletal muscle during chronic potassium depletion: Implications for hypokalemic myopathy

Journal of Proteome Research

Volumn 5, Issue 12, 2006, Pages 3326-3335

  Thongboonkerd, Visith ^a,b   Kanlaya, Rattiyaporn ^b   Sinchaikul, Supachok ^c   Parichatikanond, Paisal ^b   Chen, Shui Tein ^c,d   Malasit, Prida ^b,e  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

Enzymes; Hypokalemia; Muscle; Myopathy; Potassium; Proteome; Proteomics

Indexed keywords

ALPHA B CRYSTALLIN; ANAZOLENE SODIUM; BIOLOGICAL MARKER; CRYSTALLIN; MUSCLE ENZYME; MYOSIN BINDING PROTEIN C; MYOSIN BINDING PROTEIN H; PROTEIN; TRANSLATIONALLY CONTROLLED TUMOR PROTEIN; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHRONIC DISEASE; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; HISTOPATHOLOGY; HYPOKALEMIA; HYPOKALEMIC MYOPATHY; INTERSTITIUM; MALE; MONONUCLEAR CELL; MOUSE; MYOPATHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; POLYMORPHONUCLEAR CELL; POTASSIUM DEFICIENCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEOMICS; QUADRUPOLE MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; SKELETAL MUSCLE; STAINING; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION; HYPOKALEMIC PERIODIC PARALYSIS; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; PEPTIDE MAPPING; POTASSIUM DEFICIENCY; PROTEINS; PROTEOMICS; SEQUENCE ANALYSIS, DNA;

ANIMALIA;

EID: 33845440787     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr060136h     Document Type: Article

References (42)

1. Cohn, J. N.; Kowey, P. R.; Whelton, P. K.; Prisant, L. M. New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. Arch. Intern. Med. 2000, 160, 2429-2436.
2. Mount, D. B.; Zandi-Nejad, K. Disorders of potassium balance. In Brenner & Rector's The Kidney, 7th ed.; Brenner, B. M., Ed.; W. B. Saunders: Philadelphia, 2004; pp 997-1040.
3. Gennari, F. J. Hypokalemia. N. Engl. J. Med. 1998, 339, 451-458.
4. Gennari, F. J. Disorders of potassium homeostasis. Hypokalemia and hyperkalemia. Crit. Care Clin. 2002, 18, 273-88., vi.
5. Antes, L. M.; Kujubu, D. A.; Fernandez, P. C. Hypokalemia and the pathology of ion transport molecules. Semin. Nephrol. 1998, 18, 3I-45.
6. Tang, N. L.; Hui, J.; To, K. F.; Ng, H. K.; Hjelm, N. M.; Fok, T. F. Severe hypokalemic myopathy in Gitelman's syndrome. Muscle Nerve 1999, 22, 545-547.
7. Satoh, J.; Kuroda, Y.; Nawata, H.; Yanase, T. Molecular basis of hypokalemic myopathy caused by 17alpha-hydroxylase/17,20-lyase deficiency. Neurology 1998, 51, 1748-1751.
8. Finsterer, J.; Hess, B.; Jarius, C.; Stollberger, C.; Budka, H.; Mamoli, B. Malnutrition-induced hypokalemic myopathy in chronic alcoholism. J. Toxicol. Clin. Toxicol. 1998, 36, 369-373.
9. Allison, R. C.; Bedsole, D. L. The other medical causes of rhabdomyolysis. Am. J. Med. Sci. 2003, 326, 79-88.
10. Warren, J. D.; Blumbergs, P. C.; Thompson, P. D. Rhabdomyolysis: a review. Muscle Nerve 2002, 25, 332-347.
11. Ng, Y. C. Hypokalemia downregulates cardiac alpha 1 and skeletal muscle alpha 2 isoforms of Na+,K(+)-ATPase in ferrets. Biochem. Biophys. Res. Commun. 1993, 196, 39-46.
12. McDonough, A. A.; Thompson, C. B. Role of skeletal muscle sodium pumps in the adaptation to potassium deprivation. Acta Physiol. Scand. 1996, 156, 295-304.
13. Thompson, C. B.; Choi, C.; Youn, J. H.; McDonough, A. A. Temporal responses of oxidative vs. glycolytic skeletal muscles to K+ deprivation: Na+ pumps and cell cations. Am. J. Physiol. 1999, 276, C1411-C1419.
14. Thongboonkerd, V. Proteomic analysis of renal diseases: Unraveling the pathophysiology and biomarker discovery. Expert Rev. Proteomics 2005, 2, 349-366.
15. Marko-Varga, G.; Fehniger, T. E. Proteomics and disease - the challenges for technology and discovery. J. Proteome Res. 2004, 3, 167-178.
16. Petricoin, E.; Wulfkuhle, J.; Espina, V.; Liotta, L. A. Clinical proteomics: revolutionizing disease detection and patient tailoring therapy. J. Proteome Res. 2004, 3, 209-217.
17. Yan, J. X.; Harry, R. A.; Wait, R.; Welson, S. Y.; Emery, P. W.; Preedy, V. R.; Dunn, M. J. Separation and identification of rat skeletal muscle proteins using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 2001, 1, 424-434.
18. van den Heuvel, L. P.; Farhoud, M. H.; Wevers, R. A.; van Engelen, B. G.; Smeitink, J. A. Proteomics and neuromuscular diseases: theoretical concept and first results. Ann. Clin. Biochem. 2003, 40, 9-15.
19. Shishkin, S. S.; Kovalyov, L. I.; Kovalyova, M. A. Proteomic studies of human and other vertebrate muscle proteins. Biochemistry (Mosc.) 2004, 69, 1283-1298.
20. Cagney, G.; Park, S.; Chung, C.; Tong, B.; O'Dushlaine, C.; Shields, D. C.; Emili, A. Human tissue profiling with multidimensional protein identification technology. J. Proteome Res. 2005, 4, 1757-1767.
21. Miyada, D. S.; Dinovo, E. C.; Nakamura, R. M. Creatine kinase reactivation by thiol compounds. Clin. Chim. Acta 1975, 58, 97-99.
22. Nealon, D. A.; Henderson, A. R. The apparent Arrhenius relationships of the human creatine kinase isoenzymes using the Oliver-Rosalki assay. Clin. Chim. Acta 1976, 66, 131-136.
23. Karp, P. D.; Paley, S.; Romero, P. The Pathway Tools software. Bioinformatics 2002, 18 (Suppl 1), S225-S232.
24. Karp, P. D.; Krummenacker, M.; Paley, S.; Wagg, J. Integrated pathway-genome databases and their role in drug discovery. Trends Biotechnol. 1999, 17, 275-281.
25. Karp, P. D.; Paley, S. Integrated access to metabolic and genomic data. J. Comput. Biol. 1996, 3, 191-212.
26. Trask, R. V.; Strauss, A. W.; Billadello, J. J. Developmental regulation and tissue-specific expression of the human muscle creatine kinase gene. J. Biol. Chem. 1988, 263, 17142-17149.
27. Frederikse, P. H.; Dubin, R. A.; Haynes, J. I.; Piatigorsky, J. Structure and alternate tissue-preferred transcription initiation of the mouse alpha B-crystallin/small heat shock protein gene. Nucleic Acids Res. 1994, 22, 5686-5694.
28. Dubin, R. A.; Wawrousek, E. F.; Piatigorsky, J. Expression of the murine alpha B-crystallin gene is not restricted to the lens. Mol. Cell Biol. 1989, 9, 1083-1091.
29. Liu, Y.; Steinacker, J. M. Changes in skeletal muscle heat shock proteins: pathological significance. Front Biosci. 2001, 6, D12-D25.
30. Ganea, E. Chaperone-like activity of alpha-crystallin and other small heat shock proteins. Curr. Protein Pept. Sci. 2001, 2, 205-225.
31. Gross, B.; Gaestel, M.; Bohm, H.; Bielka, H. cDNA sequence coding for a translationally controlled human tumor protein. Nucleic Acids Res. 1989, 17, 8367.
32. Yarm, F. R. Plk phosphorylation regulates the microtubule-stabilizing protein TCTP. Mol. Cell Biol. 2002, 22, 6209-6221.
33. Benndorf, R.; Nurnberg, P.; Bielka, H. Growth phase-dependent proteins of the Ehrlich ascites tumor analyzed by one- and two-dimensional electrophoresis. Exp. Cell Res. 1988, 174, 130-138.
34. Gachet, Y.; Tournier, S.; Lee, M.; Lazaris-Karatzas, A.; Poulton, T.; Bommer, U. A. The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle. J. Cell Sci. 1999, 112 (Pt 8), 1257-1271.
35. Bommer, U. A.; Thiele, B. J. The translationally controlled tumour protein (TCTP). Int. J. Biochem. Cell Biol. 2004, 36, 379-385.
36. MacDonald, S. M.; Rafnar, T.; Langdon, J.; Lichtenstein, L. M. Molecular identification of an IgE-dependent histamine-releasing factor. Science 1995, 269, 688-690.
37. Li, F.; Zhang, D.; Fujise, K. Characterization of fortilin, a novel antiapoptotic protein. J. Biol. Chem. 2001, 276, 47542-47549.
38. Hunt, S. M.; Thomas, M. R.; Sebastian, L. T.; Pedersen, S. K.; Harcourt, R. L.; Sloane, A. J.; Wilkins, M. R. Optimal replication and the importance of experimental design for gel-based quantitative proteomics. J. Proteome Res. 2005, 4, 809-819.
39. Terry, D. E.; Desiderio, D. M. Between-gel reproducibility of the human cerebrospinal fluid proteome. Proteomics 2003, 3, 1962-1979.
40. Molloy, M. P.; Brzezinski, E. E.; Hang, J.; McDowell, M. T.; VanBogelen, R. A. Overcoming technical variation and biological variation in quantitative proteomics. Proteomics 2003, 3, 1912-1919.
41. Klein, E.; Klein, J. B.; Thongboonkerd, V. Two-dimensional gel electrophoresis: a fundamental tool for expression proteomics studies. Contrib. Nephrol. 2004, 141, 25-39.
42. Witzmann, F. A.; Li, J. Cutting-edge technology. II. Proteomics: core technologies and applications in physiology. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 282, G735-G741.